Feasibility of Peripheral Blood Sampling and Correlation Between Early and Late Responses in Patients With Ph+ CML in Chronic Phase: Post-Hoc Analyses of Molecular Monitoring of Imatinib Response in the RIGHT Study

Presented at the European School of Hematology (ESH) International Conference on Chronic Myeloid Leukemia